BioHarvest Sciences (TSE:BHSC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BioHarvest Sciences reported a remarkable 101% increase in revenue for Q3 2024, reaching over $6.5 million, surpassing management’s expectations. The company’s gross margins improved significantly, and they successfully uplisted to the Nasdaq Global Market. Their VINIA® product line, including a new SuperFood tea, contributed to strong growth and customer expansion.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
